Willis Johnson & Associates’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,050
Closed -$341K 204
2025
Q4
$341K Hold
14,050
0.02% 131
2025
Q3
$342K Hold
14,050
0.02% 129
2025
Q2
$341K Hold
14,050
0.02% 118
2025
Q1
$340K Hold
14,050
0.03% 112
2024
Q4
$337K Hold
14,050
0.03% 109
2024
Q3
$342K Hold
14,050
0.03% 116
2024
Q2
$333K Hold
14,050
0.03% 110
2024
Q1
$334K Hold
14,050
0.03% 109
2023
Q4
$336K Hold
14,050
0.03% 102
2023
Q3
$325K Hold
14,050
0.03% 98
2023
Q2
$330K Sell
14,050
-375
-3% -$8.88K 0.04% 94
2023
Q1
$344K Buy
+14,425
New +$341K 0.04% 88

Other funds holding IBDS

Willis Johnson & Associates's IBDS Position: Q1 2026 in Review

Willis Johnson & Associates sold out of iShares iBonds Dec 2027 Term Corporate ETF (IBDS) in Q1 2026, closing a stake of 14,050 shares — an estimated $341K sold.

Willis Johnson & Associates first reported a position in IBDS in Q1 2023 and held it in 12 quarters. The position peaked at $344K in Q1 2023. 428 funds tracked by Wall St. Rank hold IBDS as of Q1 2026.

  • Willis Johnson & Associates reported no remaining iShares iBonds Dec 2027 Term Corporate ETF position as of Q1 2026 after selling out during the quarter.
  • Willis Johnson & Associates sold 14,050 iShares iBonds Dec 2027 Term Corporate ETF shares in Q1 2026, an estimated $341K.
  • Willis Johnson & Associates first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q1 2023 and held it in 12 quarters.
  • Willis Johnson & Associates's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $344K in Q1 2023.
  • 428 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q1 2026.

Based on Willis Johnson & Associates's 13F filing for Q1 2026, filed 23 Apr 2026.